Cargando…

Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option

OBJECTIVE: The optimal surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction (AEG) is controversial. In this study, we evaluated the outcomes of total gastrectomy for Siewert type II/III AEG via the left thoracic surgical approach that is used at our center. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Can, Zhu, Hao-te, Xu, Zhi-yuan, Yu, Jian-fa, Du, Yi-an, Huang, Ling, Yu, Peng-fei, Wang, Li-jing, Cheng, Xiang-dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Clinical Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384491/ https://www.ncbi.nlm.nih.gov/pubmed/30296865 http://dx.doi.org/10.1177/0300060518802923

Ejemplares similares

Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: Erratum
Publicado: (2017)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
por: Duan, Xiao-Feng, et al.
Publicado: (2017)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction
por: Nagami, Yasuaki, et al.
Publicado: (2014)

Current treatments and outlook in adenocarcinoma of the esophagogastric junction: a narrative review
por: Cao, Fei, et al.
Publicado: (2022)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma
por: Nobel, Tamar, et al.
Publicado: (2019)

The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients
por: Goto, Hironobu, et al.
Publicado: (2014)

Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review
por: Doumbe-Mandengue, Paul, et al.
Publicado: (2022)

Surgical options for submucosal tumors near the esophagogastric junction: does size or location matter?
por: Huang, Yi-Chun, et al.
Publicado: (2020)

A novel surgical technique for dissection of Siewert type II adenocarcinoma of the esophagogastric junction: the transthoracic single-port assisted laparoscopic esophagogastrostomy
por: Xiong, Wenjun, et al.
Publicado: (2022)

Phase I Clinical Research of Jejunal Interposition in Adenocarcinoma of the Esophagogastric Junction II/III Proximal Gastrectomy
por: Tao, Kai, et al.
Publicado: (2016)

Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study
por: Lin, Xia, et al.
Publicado: (2021)

Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma
por: Lee, In-Seob, et al.
Publicado: (2017)

Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data
por: Chen, Jian, et al.
Publicado: (2021)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Surgical resection of gastric stump cancer following proximal gastrectomy for adenocarcinoma of the esophagogastric junction
por: Ma, Fu-Hai, et al.
Publicado: (2019)

Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction
por: Wei, Zhi-Jian, et al.
Publicado: (2022)

Utility of robotic surgery for Siewert type II/III adenocarcinoma of esophagogastric junction: transhiatal robotic versus laparoscopic approach
por: Nishi, Masaaki, et al.
Publicado: (2023)

Treatment Options for T1 Stage Adenocarcinoma of Esophagogastric Junction: A Real-World Retrospective Cohort Study
por: Zhou, Xiaoying, et al.
Publicado: (2021)

Analysis of N(6)-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
por: Huang, Jia-Bin, et al.
Publicado: (2022)

Comparison of thoracoabdominal versus abdominal-transhiatal surgical approaches in Siewert type II adenocarcinoma at the esophagogastric junction: Protocol for a prospective multicenter randomized controlled trial
por: Yue, Chao, et al.
Publicado: (2023)

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
por: Zhou, Zhangjian, et al.
Publicado: (2015)

Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma
por: Li, Haijun, et al.
Publicado: (2017)

Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
por: Laxague, Francisco, et al.
Publicado: (2021)

Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis
por: Shi, Yinan, et al.
Publicado: (2018)

Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction
por: Tian, Yuan, et al.
Publicado: (2021)

Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
por: Sun, Lidan, et al.
Publicado: (2014)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma
por: Wang, Zhao Yang, et al.
Publicado: (2021)

The abdominal-transhiatal surgical approach versus the thoracoabdominal surgical approach in Siewert type II adenocarcinoma of the esophagogastric junction: protocol for a multicenter prospective, open, parallel, and randomized controlled trial
por: Song, Qiying, et al.
Publicado: (2022)

The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma
por: Li, Zheng, et al.
Publicado: (2021)

Comparison of survival outcomes between transthoracic and transabdominal surgical approaches in patients with Siewert-II/III esophagogastric junction adenocarcinoma: a single-institution retrospective cohort study
por: Zhang, Weihan, et al.
Publicado: (2016)

The length of proximal margin does not influence the prognosis of Siewert type II/III adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy
por: Feng, Fan, et al.
Publicado: (2016)

Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up
por: Hosoda, Kei, et al.
Publicado: (2017)

Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China
por: Zhang, Hao, et al.
Publicado: (2013)

Can proximal Gastrectomy Be Justified for Advanced Adenocarcinoma of the Esophagogastric Junction?
por: Sato, Yuya, et al.
Publicado: (2018)

MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction
por: Just, Christina, et al.
Publicado: (2019)

Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
por: Xu, Haitao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dc8m14iapul64ea3b4fkos6sbk